
|Articles|June 1, 1996
Supplements and Featured Publications
- Managing the Patient at Risk for NSAID Toxicity Consensus Conference
- Volume 2
- Issue 8 Suppl
Overview of the Physiology of COX-1 and COX-2 and Selectivity of NSAIDs
Author(s)Jan Ake Lindgren, MD, PhD
Advertisement
Articles in this issue
over 29 years ago
Participantsover 29 years ago
Goals and Long-Term Management of Arthritis with NSAIDsover 29 years ago
Defining the Patient at Risk for NSAID Toxicityover 29 years ago
GI Toxicity of NSAIDs: Incidence, Complications, Management StrategyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
3
HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances
4
FDA Approves Intranasal Etripamil for Type of Arrhythmia
5









































